The need we address: 10 million people worldwide are diagnosed with Parkinson’s disease. This number will double by 2040. There is no cure yet. Parkinson’s disease is very complex as over 60 symptoms can occur, and the progression of the disease is highly individual. The lack of touch-points between the patient, the neurologist and other care providers can create delays in adapting the individual care path. This affects the patient’s quality of life and increases health costs unnecessarily, thus placing a tremendous burden on patients, their families and the healthcare system. The solution we envision: NeuroPath builds a digital platform to connect the daily living of the patient with the interdisciplinary team of care providers and clinicians. We use patient-centric, smart and non-intrusive technologies in motion capturing, patient reported outcomes, voice analysis and wearables to collect data and detect specific events and disease progression. Our real-world data collection and proprietary software create insights to better understand patients’ motor and non-motor symptoms and to adapt the care path accordingly for an improved quality of life at a lower healthcare cost. The opportunities and added value we strive to realize: - For patients & caregivers: a better quality of life - For clinicians and care providers: real-time insights into patients’ well-being and impact of treatment - For Pharma and Clinical Research Organizations: efficacy and lower costs - For health insurance payers: lower economic burden through improved efficiencies